drug candidate antibodies

U3 Pharma Has Signed a Research Collaboration Deal with AbCheck
Feb 19, 2013
U3 Pharma, an antibody targeted cancer drug development affiliate of Daiichi Sankyo, has signed a research collaboration deal with AbCheck. AbCheck's commercial multi antibody discovery platforms include AbSieve, which combines the ...

Tags: Pharma, cancer drug, drug candidate antibodies